HR Execs on the Move

Endo

www.endo.com

 
Endo International plc is a highly focused generics and specialty pharmaceutical company delivering quality medicines through excellence in development, manufacturing and commercialization. Through our operating companies – Endo Pharmaceuticals, Par Pharmaceutical and Paladin Labs – Endo is dedicated to serving patients in need. Endo commenced operations in 1997 by acquiring certain pharmaceutical products, related rights and assets from The DuPont Merck Pharmaceutical Company. Since that time, the company has expanded to include the following business segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals and International Pharmaceuticals. Endo`s strategy is to centralize and unify our business, driving productivity improvements. We will focus ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.endo.com
  • 1400 Atwater Drive
    Malvern, PA USA 19355
  • Phone: 484.216.0000

Executives

Name Title Contact Details
Monette Ablan
 Senior Director, Enterprise Compensation Profile
Rosalie Filling
 Vice President, Global Head R&D Operations Profile
Henry Wolfe
 Vice President, Biologics Research & Development Profile
James Tursi
 Executive Vice President, Global Research and Development Profile
Matthew Davis
 Chief Scientific Officer, SVP Global Branded R&D Profile

Jobs

Chief Information Security Officer

Endo Malvern, PA

Similar Companies

Kane Veterinary Supplies

Kane Veterinary Supplies Ltd. is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Maag Prescription

Maag Prescription is a Pocatello, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PleoPharma

Therapy designed to address an unmet and growing need in the CNS and substance abuse space.

SAB Biotherapeutics

SAB Biotherapeutics, Inc. (SAB) is a clinical-stage, biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. SAB has applied advanced genetic engineering and antibody science to develop transchromosomic (Tc) Bovine™ herds that produce fully-human antibodies targeted at specific diseases, including infectious diseases such as COVID-19 and influenza, immune system disorders including type 1 diabetes and organ transplantation, and cancer. SAB`s versatile DiversitAb™ platform is appliable to a wide range of serious unmet needs in human diseases. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB is currently advancing multiple clinical programs and has a number of collaborations with the US government and global pharmaceutical companies.

Crucell Biologics

Crucell N.V. (Crucell) is a biopharmaceutical company. The Company is focused on developing, producing and marketing products that combat infectious diseases. Crucell product candidates include flu-mAb, an antibody product effective against a range of